Skip to main content
Premium Trial:

Request an Annual Quote

Agilent s LSCA Unit Posts Double-Digit Growth in Orders, Revenues for Q1 2005

NEW YORK, Feb. 14 (GenomeWeb News) - Agilent Technologies' Life Science and Chemical Analysis business unit today reported a 16-percent increase in orders for the quarter ended Jan. 31, 2005, accompanied by a 13-percent rise in revenues and a 9-percent increase in profits.

 

Agilent's LSCA group, which houses the company's genomics and proteomics product lines, reported orders of $356 million for the first quarter of its 2005 fiscal year, up sharply from $307 million in orders for the year-ago quarter.

 

Life Science orders increased 18 percent, while Chemical Analysis orders increased by 15 percent, the company said.

 

The LSCA unit posted first-quarter revenues of $354 million, compared to $313 million in the first quarter of fiscal 2004.

 

Segment profits rose to $51 million, from $47 million in the prior-year period. 

 

The LSCA unit's revenues made up 21 percent of Agilent's $1.66 billion in total revenues for the quarter, which rose only 1 percent over last year's first-quarter revenues.

 

Total orders for the company - including LSCA, Test and Measurement, Automated Test, and Semiconductor Products - dropped 7 percent year-over-year to $1.61 billion.

 

First-quarter net earnings were $103 million, or $.21 per diluted share, compared to $71 million, or $.14 per share, in the first quarter of 2004.

 

Agilent spent a total of $232 million on R&D during the quarter, up slightly from $229 million last year.

 

The company had $2.5 billion in cash and cash equivalents on hand as of Jan. 31.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.